Intermittent versus continuous neuroleptic treatment in a rat model

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Neuroleptic therapy schedules influence the development of drug-induced side effects.
• Understanding these side effects is crucial for patient safety and treatment efficacy.
• Movement disorders are common side effects of neuroleptic medications.

Purpose of the Study:

• To investigate the impact of discontinuous versus continuous neuroleptic treatment on behavioral side effects.
• To compare the effects of dopamine D2 (haloperidol) and D1/D2 (zuclopenthixol) receptor blockers.
• To explore the potential for pharmacological sensitization to neuroleptic-induced dyskinesias.

Main Methods:

• Seventy-five rats received either haloperidol or zuclopenthixol for 15 weeks.
• Treatment was administered continuously or discontinuously.
• Behavioral parameters, including vacuous chewing movements and tongue protrusions, were monitored during and after treatment.

Main Results:

• Discontinuous neuroleptic treatment led to a significant, long-lasting increase in oral activity compared to continuous treatment.
• This effect was most pronounced in rats treated with haloperidol.
• Observed changes suggest potential methodological implications for animal models of neuroleptic-induced movement disorders.

Conclusions:

• Intermittent exposure to neuroleptics may induce pharmacological sensitization to dyskinetic side effects.
• Treatment schedules significantly influence the manifestation and persistence of neuroleptic-induced oral activity.
• Findings support the hypothesis that allowing drug effects to wane between administrations promotes sensitization.